Amerithroid (thyroid) NDC 82685-342

NDC codes

FDA NDC Directory

Product NDC (as listed)82685-342Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82685-0342Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82685-342-01	82685034201	100 TABLET in 1 BOTTLE (82685-342-01)Marketed from May 7, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amerithroid
Generic name (nonproprietary): thyroid
Active ingredients: Thyroid — 30 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Oliva Therapeutics, LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: May 7, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 82685-342_15d44dfd-e076-49df-89ef-ff40772e4b3eSPL ID 15d44dfd-e076-49df-89ef-ff40772e4b3eSPL set ID 03e79049-65b2-4f47-9c98-7ebb324cbc14RxCUI 198278, 208545, 313385, 313387, 313391, 313393, 314267, 315235, 2743051, 2743053, 2743055, 2743057, 2743059, 2743061, 2743063, 2743065UNII 6RV024OAUQUPC 0382685346018, 0382685341013, 0382685343017, 0382685342010, 0382685348012, 0382685344014, 0382685345011, 0382685347015

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482685034201 followed by a unit qualifier and the quantity

Package 82685-0342-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 13, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Amerithroid® (Thyroid Tablets, USP) are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WARNINGS )…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)